
QUEST DIAGNOSTICS INC
DGXNYSETrading Snapshot
- Day Range
- $234.24 β $241.41
- 52-Week Range
- $171.18 β $240.13
- Volume
- $4.54B
- Avg Volume
- $3.22B
- Shares Outstanding
- 110.4M
- Next Earnings
- Sep 14, 2026
Fundamentals Snapshot
- Annual Revenue
- $11.04B
- Last Q Revenue
- $3.04B
- P/E Ratio
- 24.6
- P/S Ratio
- 2.3x
- EPS (TTM)
- $9.44
- Dividend Yield
- 1.39%
Why Investors Own DGX
- βHigh-growth profile β revenue up +37.5% YoY with expanding US Equity exposure.
- βHealthy economics β 40% gross margin and 12% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About QUEST DIAGNOSTICS INC
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
QUEST DIAGNOSTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift DGX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
QUEST DIAGNOSTICS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.